Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Department of Rheumatology, Internal Medicine III, Medical University of Vienna

Femme et Homme Max 99 ans
Department of Rheumatology, Internal Medicine III, Medical University of Vienna MAJ Il y a 5 ans

A Double Blind, Randomized, Placebo Controlled, Multi-Center Trial of Anti-TNFafa Chimeric Monoclonal Antibody (Infliximab, Remicade®) and Azathioprine in Patients Suffering from Systemic Lupus Erythematosus (SLE) with WHO Class V Glomerulonephritis To prove that infliximab in combination with azathioprine is superior to azathioprine alone in rapidly inducing a meaningful renal improvement, defined as a reduction in proteinuria of at least 50%, i...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations